139 related articles for article (PubMed ID: 8082918)
41. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
42. Genetically engineered mouse models of mammary intraepithelial neoplasia.
Cardiff RD; Moghanaki D; Jensen RA
J Mammary Gland Biol Neoplasia; 2000 Oct; 5(4):421-37. PubMed ID: 14973386
[TBL] [Abstract][Full Text] [Related]
43. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.
Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ
Oncogene; 2003 Dec; 22(57):9151-5. PubMed ID: 14668796
[TBL] [Abstract][Full Text] [Related]
44. [The similarity of the pathogenesis of dyshormonal mammary gland changes in mice under various conditions].
Dmitriev VN
Vopr Onkol; 1971; 17(2):59-62. PubMed ID: 5567710
[No Abstract] [Full Text] [Related]
45. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021
[TBL] [Abstract][Full Text] [Related]
46. Expression of mouse mammary tumor virus envelope protein does not prevent superinfection in vivo or in vitro.
Dzuris JL; Zhu W; Kapkov D; Golovkina TV; Ross SR
Virology; 1999 Oct; 263(2):418-26. PubMed ID: 10544114
[TBL] [Abstract][Full Text] [Related]
47. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
[TBL] [Abstract][Full Text] [Related]
48. The mouse as a model for mammary tumorigenesis: history and current aspects.
Callahan R; Smith GH
J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):269. PubMed ID: 18712586
[No Abstract] [Full Text] [Related]
49. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
50. Symposium on Mammary Neoplasia. Introductory remarks.
Moore DH
J Natl Cancer Inst; 1972 Apr; 48(4):1017-9. PubMed ID: 4336865
[No Abstract] [Full Text] [Related]
51. Some aspects of the morphology of the Bittner virus.
Clarke JK; Attridge JT
J Natl Cancer Inst; 1970 Apr; 44(4):755-62. PubMed ID: 11515042
[No Abstract] [Full Text] [Related]
52. Mammary tumorigenesis through irradiation of mice.
Warren S; Gates O
Radiat Res; 1974 Mar; 57(3):488-507. PubMed ID: 10874963
[No Abstract] [Full Text] [Related]
53. Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice.
Kosanke S; Edgerton SM; Moore D; Yang X; Mason T; Alvarez K; Jones L; Kim A; Thor AD
Comp Med; 2004 Jun; 54(3):280-7. PubMed ID: 15253274
[TBL] [Abstract][Full Text] [Related]
54. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
55. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.
Ahmed F; Wyckoff J; Lin EY; Wang W; Wang Y; Hennighausen L; Miyazaki J; Jones J; Pollard JW; Condeelis JS; Segall JE
Cancer Res; 2002 Dec; 62(24):7166-9. PubMed ID: 12499251
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY
Cancer Res; 2001 Feb; 61(3):984-90. PubMed ID: 11221894
[TBL] [Abstract][Full Text] [Related]
57. Behaviour and morphology of pregnancy responsive mammary tumours in mice.
van Nie R
Pathol Eur; 1967; 2(4):357-73. PubMed ID: 4296489
[No Abstract] [Full Text] [Related]
58. Tumours of the mammary gland.
Cardesa A; Handler AH; Kelman AD
IARC Sci Publ; 1982; (34):33-7. PubMed ID: 7169260
[No Abstract] [Full Text] [Related]
59. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
60. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
